Current Opinion in Allergy and Clinical Immunology was launched in 2001. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of allergy and clinical immunology are divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Dr Milgrom has been on the staff of National Jewish Health (formerly National Jewish Medical and Research Center) in Denver, USA for nearly 25 years. He holds the appointment of Professor of Pediatrics at the University of Colorado School of Medicine, USA. He treats both adult and pediatric patients who suffer from allergic disorders, asthma, chronic cough, vocal cord dysfunction and atopic dermatitis.
Dr Milgrom believes that the greatest challenge for healthcare in the 21st century is to provide effective and cost-effective health management, especially as it pertains to chronic illness. Today's medicine is reactive. In effect, we’re practicing 19th century medicine in the 21st century. We treat the sick – most often empirically with drugs chosen on the basis of common use. In the case of asthma, the patients and we use medications imperfectly resulting in suboptimal outcomes with unnecessary morbidity and cost. Healthcare of the future will be predictive and personalized. Systems medicine will become a major paradigm in clinical research, much as systems biology has become in the natural sciences. It will allow us to target therapy on a personalized basis for those who need it, avoiding treatment for those who do not. The strategy will center on a new personal health record that provides integrated and comprehensive views of the health of an individual and his place within a population. New technologies and availability of large databases will profoundly alter the way that outcomes research is conducted and knowledge is conveyed. It appears ever more probable that such information will provide unmatched understanding of a patient's condition, including susceptibility to disease and its progression, as well as likely drug responsiveness. The goal of the right drug for the right patient at the right time just might be attainable.
With the capacity to inject this new intelligence into health delivery, our challenge will be to put the patient first and not to lose track of what it takes to be a good doctor.
University Professor Ralph Mösges, FAAAAI (MD, PhD) is an otorhinolaryngologist and allergist. He resides in Cologne, Germany. Ralph Mösges is a Professor of Medical Informatics at the Institute of Medical Statistics, Informatics and Epidemiology at the University of Cologne in Germany. He has previously been a Consultant for otorhinolaryngology and responsible for the ORL Allergy Clinic at the University Hospital, Medical Faculty of Aachen, Germany. His current major research fields are allergology, epidemiology, and clinical pharmacology of infectious diseases.
Ralph Mösges is the author and editor of seven books and has published more than 150 articles. Professor Mösges is a member of the German, the European and the American Academies of Allergy and Clinical Immunology, and of the German Academy of Otorhinolaryngology, for which he serves on the guidelines committee.
Alessandro Fiocchi MD is the Director of Paediatrics at the Fatebenefratelli-Melloni University Hospital in Milan, Italy. Alessandro Fiocchi is an expert in the field of food allergy. After post-graduate degrees and professional qualification in paediatrics, allergology, pulmonology, and neonatology, he dedicated his research and clinical work to the care of children with asthma and allergic disease. Currently, he leads a research group focusing on food, cow's milk and beef allergies, asthma, and specific immunotherapy. This group is based in the Maternal and Child Medicine Department of a University Hospital in Milan, Italy, which includes an emergency pediatric department. Since 2001, he has organized international meetings in Milan, Italy, and other countries. He has founded and presides over the Italian Research Foundation for Allergy and Asthma in Childhood – Allegria ONLUS, a charity dedicated to clinical and research studies. As chair of the Adverse Reactions to Foods Committee of the American College of Allergy, Asthma, and Immunology, he co-chaired with Sami Bahna the XI International Food Allergy Symposium, New Orleans, LA, USA, in 2003. During the World Allergy Congress 2007 of Bangkok he and Hugh Sampson were co-chairs of the Food Allergy Symposium. Starting in January 2008, Dr. Fiocchi is the Chair of the Special Committee on Food Allergy of the World Allergy Organization. His publications cover the fields of food allergy diagnosis, follow-up, epidemiology, specific immunotherapy and childhood asthma.
Julie Wang MD is an Assistant Professor of Pediatrics at the Mount Sinai School of Medicine in New York, USA. She graduated from the Weill Cornell Medical College in New York City, USA. She completed pediatric residency training at the New York-Presbyterian/Weill Cornell Medical Center in New York, USA and an allergy and immunology fellowship program at the Mount Sinai School of Medicine in New York, USA. She received the American Academy of Allergy, Asthma, and Immunology/Elliot and Roslyn Jaffe Third- Year Fellowship award in 2005.
Dr Wang is an expert in the field of food allergy. Her current research focus is on novel therapeutic approaches to food allergy using traditional Chinese medicine; she has been awarded a 5-year National Institutes of Health grant to support this work. Her publications cover the fields of food allergy diagnosis, epidemiology, and therapeutics as well as asthma and food allergy in urban children. Dr Wang is a member of the American Academy of Asthma, Allergy and Immunology, American Academy of Pediatrics, and Society for Pediatric Research.